Our study establishes M1-/M2-like markers CXCL10 and CCL13 for informative and reliable detection of GBM associated microglia/macrophage polarization in conjunction with a defined protease profile as molecular determinants for GBM progression. The gene discussed is CXCL10; the disease is glioblastoma.